| Hailee Brooke Taylor, NP | |
|
440 Hometown Plaza Dr, Owensville, MO 65066-1596 | |
| (573) 437-6100 | |
| Not Available |
| Full Name | Hailee Brooke Taylor |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 440 Hometown Plaza Dr, Owensville, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467095356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2019039842 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Washington | Washington, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic East Communities | 7214827922 | 491 |
News Archive
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc.,, today announced the presentation of detailed results from the Phase III SUCCEED clinical trial. SUCCEED evaluated oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.
In a new paper, Northeastern University Professor of Marketing Samuel Rabino, Dr. Howard Moskowitz, President of Moskowitz and Jacobs Inc. and colleagues analyze the consumption patterns of 6,700 respondents' evaluation of 22 food and beverage products in three countries, creating a comprehensive database of their findings.
Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.
Royal Philips, a global health technology company, today announced the release of the IntelliVue X3 in Europe. Designed for portable, uninterrupted monitoring during in-hospital transport and at the bedside, IntelliVue X3 provides an intuitive smart-phone-style operation that quickly and easily enables continuous monitoring during transport for the most critical patients.
› Verified 6 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073739041 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000058 |
News Archive
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc.,, today announced the presentation of detailed results from the Phase III SUCCEED clinical trial. SUCCEED evaluated oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.
In a new paper, Northeastern University Professor of Marketing Samuel Rabino, Dr. Howard Moskowitz, President of Moskowitz and Jacobs Inc. and colleagues analyze the consumption patterns of 6,700 respondents' evaluation of 22 food and beverage products in three countries, creating a comprehensive database of their findings.
Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.
Royal Philips, a global health technology company, today announced the release of the IntelliVue X3 in Europe. Designed for portable, uninterrupted monitoring during in-hospital transport and at the bedside, IntelliVue X3 provides an intuitive smart-phone-style operation that quickly and easily enables continuous monitoring during transport for the most critical patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hailee Brooke Taylor, NP 136 Lois Ln, Sullivan, MO 63080-2697 Ph: (314) 640-2878 | Hailee Brooke Taylor, NP 440 Hometown Plaza Dr, Owensville, MO 65066-1596 Ph: (573) 437-6100 |
News Archive
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc.,, today announced the presentation of detailed results from the Phase III SUCCEED clinical trial. SUCCEED evaluated oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.
In a new paper, Northeastern University Professor of Marketing Samuel Rabino, Dr. Howard Moskowitz, President of Moskowitz and Jacobs Inc. and colleagues analyze the consumption patterns of 6,700 respondents' evaluation of 22 food and beverage products in three countries, creating a comprehensive database of their findings.
Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.
Royal Philips, a global health technology company, today announced the release of the IntelliVue X3 in Europe. Designed for portable, uninterrupted monitoring during in-hospital transport and at the bedside, IntelliVue X3 provides an intuitive smart-phone-style operation that quickly and easily enables continuous monitoring during transport for the most critical patients.
› Verified 6 days ago
John A Declue, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 3536 Kuhne Rd, Owensville, MO 65066 Phone: 573-437-4168 Fax: 573-437-4242 | |
James W Keith, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 708 E Highway 28, Owensville, MO 65066 Phone: 573-437-4481 Fax: 573-437-3232 | |
Brian R Edwards, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3536 Kuhne Rd, Owensville, MO 65066 Phone: 573-437-4168 Fax: 573-437-4168 | |
Megan L Stutheit, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 440 Hometown Plaza Dr, Owensville, MO 65066 Phone: 573-437-6100 |